1. A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
- Subjects
Immunoproteins -- Physiological aspects ,Immunoproteins -- Health aspects ,Drug resistance in microorganisms -- Physiological aspects ,Drug resistance in microorganisms -- Health aspects ,Bacterial pneumonia -- Physiological aspects ,Bacterial pneumonia -- Health aspects ,Pneumonia -- Physiological aspects ,Pneumonia -- Health aspects ,Lectins -- Physiological aspects ,Lectins -- Health aspects ,Proteolysis -- Physiological aspects ,Proteolysis -- Health aspects ,Microbial polysaccharides -- Physiological aspects ,Microbial polysaccharides -- Health aspects ,Biological sciences - Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.cell.2006.01.046 Byline: Young-Sun Kang (1), Yoonkyung Do (1), Hae-Kyung Lee (1), Sung Ho Park (1), Cheolho Cheong (1), Rebecca M. Lynch (1), Jutta M. Loeffler (2), Ralph M. Steinman (1), Chae Gyu Park (1) Abstract: The intricate system of serum complement proteins provides resistance to infection. A pivotal step in the complement pathway is the assembly of a C3 convertase, which digests the C3 complement component to form microbial binding C3 fragments recognized by leukocytes. The spleen and C3 provide resistance against blood-borne S. pneumoniae infection. To better understand the mechanisms involved, we studied SIGN-R1, a lectin that captures microbial polysaccharides in spleen. Surprisingly, conditional SIGN-R1 knockout mice developed deficits in C3 catabolism when given S. pneumoniae or its capsular polysaccharide intravenously. There were marked reductions in proteolysis of serum C3, deposition of C3 on organisms within SIGN-R1.sup.+ spleen macrophages, and formation of C3 ligands. We found that SIGN-R1 directly bound the complement C1 subcomponent, C1q, and assembled a C3 convertase, but without the traditional requirement for either antibody or factor B. The transmembrane lectin SIGN-R1 therefore contributes to innate resistance by an unusual C3 activation pathway. Author Affiliation: (1) Laboratory of Cellular Physiology and Immunology and Chris Browne Center for Immunology and Immune Diseases, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA (2) Laboratory of Bacterial Pathogenesis, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA Article History: Received 11 October 2005; Revised 26 December 2005; Accepted 17 January 2006 Article Note: (miscellaneous) Published: April 6, 2006
- Published
- 2006